Anorexia
Information
- Disease name
- Anorexia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03637816 | Active, not recruiting | Phase 2/Phase 3 | Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer | November 27, 2018 | December 31, 2024 |
| NCT00488072 | Active, not recruiting | Phase 2 | Effects of Mirtazapine on Appetite in Advanced Cancer Patients | September 20, 2006 | December 31, 2025 |
| NCT00002345 | Completed | Phase 4 | The Safety and Effectiveness of Megace in HIV-Infected Women | ||
| NCT00006799 | Completed | Phase 3 | Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer | October 1, 2000 | September 6, 2002 |
| NCT00031707 | Completed | Phase 3 | Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite | March 2000 | January 2004 |
| NCT00031785 | Completed | Phase 3 | Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer | September 1, 2000 | September 11, 2002 |
| NCT00040885 | Completed | Phase 3 | Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) | October 2002 | October 2008 |
| NCT00046904 | Completed | Phase 3 | Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer | May 2003 | |
| NCT00081250 | Completed | Phase 3 | Creatine in Treating Patients With Cancer-Associated Weight Loss | December 2004 | July 2017 |
| NCT00316563 | Completed | Phase 2 | Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study | August 2006 | November 2009 |
| NCT00002067 | Completed | Phase 3 | A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia | ||
| NCT05708404 | Completed | Outpatient Treatment of Severe and Enduring Anorexia Nervosa | May 1, 2017 | May 31, 2022 | |
| NCT05418270 | Completed | Anorexia and Personality Traits in Elderly Individuals | June 2, 2022 | August 1, 2022 | |
| NCT00637572 | Completed | Phase 2 | Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss | December 2004 | June 2005 |
| NCT04803305 | Completed | Phase 1 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | May 11, 2021 | August 9, 2022 |
| NCT04748523 | Completed | N/A | Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia | August 29, 2018 | October 29, 2022 |
| NCT00735540 | Completed | Clinical Diagnosis of Teenagers Admitted to Pediatric Departments | May 2008 | May 2010 | |
| NCT00829946 | Completed | N/A | Effects of Resistance Strength Training on Functional Capacity and Well Being of Anorexic Patients | January 2008 | March 2008 |
| NCT04220112 | Completed | N/A | Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa | March 1, 2020 | September 30, 2022 |
| NCT04007900 | Completed | N/A | Positive Affect Treatment (PAT) to Target Reward Mechanisms in Anorexia Nervosa | May 31, 2019 | March 31, 2023 |
| NCT01259999 | Completed | N/A | Energy Dense Formula to People Living in Old Peoples Home | April 2010 | May 2011 |
| NCT03028545 | Completed | N/A | Representations and Strategies for Recovery | January 4, 2017 | March 31, 2020 |
| NCT00002300 | Completed | Phase 2 | A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition | ||
| NCT02830620 | Completed | N/A | Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy | August 1, 2012 | December 24, 2019 |
| NCT01397214 | Completed | Phase 1 | Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers | July 2011 | January 2012 |
| NCT03439553 | Completed | N/A | Estimating the Short-term Effectiveness of Online Advertisements for Improving Health | April 16, 2015 | July 1, 2017 |
| NCT03283488 | Completed | Phase 2 | Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care. | March 26, 2019 | February 2, 2022 |
| NCT03097874 | Completed | N/A | Adaptive Treatment for Adolescent Anorexia Nervosa | September 1, 2017 | October 5, 2022 |
| NCT01849107 | Completed | N/A | Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity | April 2013 | December 2014 |
| NCT01941810 | Completed | N/A | Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy | February 2014 | October 2015 |
| NCT02050490 | Completed | Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study | January 2014 | December 2016 | |
| NCT02148042 | Completed | Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa | April 2014 | July 2016 | |
| NCT02333500 | Completed | N/A | Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa | February 11, 2015 | December 31, 2018 |
| NCT02445378 | Completed | N/A | Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy | December 28, 2014 | November 5, 2016 |
| NCT02524301 | Completed | N/A | Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study | September 2009 | July 29, 2016 |
| NCT06146075 | Not yet recruiting | Insights Into Participating in Clinical Studies for Anorexia | December 2024 | December 2026 | |
| NCT06154525 | Recruiting | N/A | Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Children | March 10, 2024 | July 30, 2024 |
| NCT04939090 | Recruiting | Phase 3 | Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | January 3, 2022 | December 2026 |
| NCT05503147 | Recruiting | Phase 1 | Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) | March 24, 2022 | September 1, 2023 |
| NCT01200602 | Terminated | Phase 2 | Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy | March 2011 | January 2012 |
| NCT00637806 | Terminated | Phase 3 | Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension | June 2006 | September 2006 |
| NCT00637728 | Terminated | Phase 3 | Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients | June 2006 | September 2006 |
| NCT00535015 | Terminated | Phase 2 | Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer | October 2007 | August 2008 |
| NCT00558558 | Terminated | Phase 2 | Haelan and Nutrition in Cancer Patients | October 2007 | August 2009 |
| NCT03118921 | Terminated | N/A | Body Image Disorder in Anorexia Nervosa and Virtual Reality | April 20, 2017 | October 31, 2019 |
| NCT04923087 | Unknown status | Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021) | June 1, 2021 | November 30, 2021 | |
| NCT04981626 | Unknown status | Interoception in Anorexia Nervosa | February 14, 2022 | April 2023 | |
| NCT02619266 | Unknown status | Phase 2/Phase 3 | The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers | December 2015 | February 2017 |
| NCT01678014 | Unknown status | Phase 1 | Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia Nervosa | April 2012 | December 2012 |
| NCT01540019 | Unknown status | Phase 1/Phase 2 | Paullinia Cupana for Anorexia in Oncologic Patients | April 2011 | July 2013 |
| NCT03535714 | Unknown status | N/A | Maudsley Model of Anorexia Nervosa Treatment for Adolescents and Young Adults (MANTR-a) | April 25, 2018 | August 31, 2022 |
| NCT01295450 | Unknown status | Phase 3 | Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex | April 2011 | August 2011 |
| NCT01206335 | Unknown status | Phase 2 | Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia | September 2010 | February 2013 |
| NCT05243251 | Unknown status | Phase 3 | Olanzapine Anorexia Cachexia | December 25, 2021 | September 2022 |
| NCT05380479 | Unknown status | Phase 2 | Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients. | June 1, 2022 | February 1, 2023 |
| NCT00369876 | Unknown status | Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems | August 2004 | July 2006 | |
| NCT02802540 | Unknown status | Phase 2/Phase 3 | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients | December 2014 | July 2017 |
| NCT05039385 | Withdrawn | N/A | Exercise Program in Patients With Anorexia Nervosa (ESATRAL) | September 1, 2021 | July 30, 2023 |
| NCT02793102 | Withdrawn | N/A | Sensory Workshops and Anorexia Nervosa | September 2012 | March 2015 |
| NCT01501396 | Withdrawn | Phase 2 | Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite | September 2013 | September 2015 |
| NCT00425906 | Withdrawn | N/A | Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer | December 2003 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002039
- ICD10 preferred id (Insert disease from ICD10)
- D0015163
- ICD10 class code (Insert disease from ICD10)
- R63.0
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000855